|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.91 USD | +0.82% |
|
-1.60% | -45.38% |
| Mar. 20 | ILJIN SNT Delivers a Letter to Aurinia Pharmaceuticals | CI |
| Mar. 07 | Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing | MT |
Aurinia Pharmaceuticals Inc. (NasdaqGM:AUPH) announces a share repurchase program. Under the program, the company will repurchase up to $150 million worth of its shares. The maximum amount of the share repurchase program is subject to receipt of regulatory approval in Canada.
The expiry date of the share repurchase program is not currently known.
| 1st Jan change | Capi. | |
|---|---|---|
| -45.38% | 710M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
AURINIA PHARMACEUTICALS INC. 
